144 related articles for article (PubMed ID: 11708024)
1. [A case of locally advanced breast cancer treated with hyperthermia in combination with radiotherapy].
Yamasaki M; Yayoi E; Kishibuchi M; Nishi T; Yagyu T; Kawasaki K; Ostapenko V; Nishide T
Gan To Kagaku Ryoho; 2001 Oct; 28(11):1746-8. PubMed ID: 11708024
[TBL] [Abstract][Full Text] [Related]
2. [Two cases of breast cancer markedly responded to neoadjuvant chemoendocrine therapy (2 cycles of CMF and tamoxifen, pCR and near pCR)].
Rai Y; Sagara Y; Sagara Y; Ooi Y
Gan To Kagaku Ryoho; 2004 Mar; 31(3):443-7. PubMed ID: 15045959
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial.
Sverrisdottir A; Nystedt M; Johansson H; Fornander T
Breast Cancer Res Treat; 2009 Oct; 117(3):561-7. PubMed ID: 19153828
[TBL] [Abstract][Full Text] [Related]
4. [High-dose CEF (cyclophosphamide, epirubicin, fluorouracil) as primary chemotherapy in locally advanced breast cancer: long-term results].
Conti F; Carpano S; Sergi D; Di Lauro L; Amodio A; Vici P; Abbate MI; Ferranti FR; Viola G; Botti C; Foggi P; Sperduti I; Lopez M
Clin Ter; 2007; 158(4):331-41. PubMed ID: 17953285
[TBL] [Abstract][Full Text] [Related]
5. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials.
Taghian A; Jeong JH; Mamounas E; Anderson S; Bryant J; Deutsch M; Wolmark N
J Clin Oncol; 2004 Nov; 22(21):4247-54. PubMed ID: 15452182
[TBL] [Abstract][Full Text] [Related]
6. [A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant setting].
Inaji H; Sakai K; Oka T; Ozawa K; Saito Y; Senoo T; Taguchi T; Terasawa T; Nakao K; Mori T; Koyama H; Oshima A
Gan To Kagaku Ryoho; 2006 Oct; 33(10):1423-9. PubMed ID: 17033231
[TBL] [Abstract][Full Text] [Related]
7. [A case of giant advanced breast cancer responding remarkably to CEFT therapy].
Yano M; Kume K; Ono E; Wakasugi K; Matsuzaka T; Fujinaga H
Gan To Kagaku Ryoho; 1993 Jun; 20(8):1067-70. PubMed ID: 8512336
[TBL] [Abstract][Full Text] [Related]
8. [A case report of advanced breast cancer with remarkable response to chemoendocrine therapy (CTF + MPA)].
Yokota T; Fujii T; Roppongi T; Kanno K; Ogata T
Gan To Kagaku Ryoho; 1998 Apr; 25(5):739-42. PubMed ID: 9571973
[TBL] [Abstract][Full Text] [Related]
9. Long-term local hyperthermia in the treatment of advanced breast cancer (case report).
Ostapenko VV; Yamazaki M; Nishide T; Tanaka H; Miyano M; Sonobe M; Toda K; Mune M; Nishide I; Yukawa S
Anticancer Res; 2001; 21(6A):4117-9. PubMed ID: 11911304
[TBL] [Abstract][Full Text] [Related]
10. Cyclophosphamide, methotrexate and fluorouracil (CMF) versus hormonal ablation with leuprorelin acetate as adjuvant treatment of node-positive, premenopausal breast cancer patients: preliminary results of the TABLE-study (Takeda Adjuvant Breast cancer study with Leuprorelin Acetate).
Schmid P; Untch M; Wallwiener D; Kossé V; Bondar G; Vassiljev L; Tarutinov V; Kienle E; Lüftner D; Possinger K;
Anticancer Res; 2002; 22(4):2325-32. PubMed ID: 12174922
[TBL] [Abstract][Full Text] [Related]
11. [An elderly woman with breast cancer and multiple liver metastasis that responded well to combination therapy of fadrozole and tamoxifen].
Nakajima Y; Hirayama K; Saitoh K; Terashima H; Shimada T; Nishiyama S; Shimizu T
Gan To Kagaku Ryoho; 2001 Dec; 28(13):2065-8. PubMed ID: 11791386
[TBL] [Abstract][Full Text] [Related]
12. Sequencing of tamoxifen and radiotherapy after breast-conserving surgery in early-stage breast cancer.
Pierce LJ; Hutchins LF; Green SR; Lew DL; Gralow JR; Livingston RB; Osborne CK; Albain KS
J Clin Oncol; 2005 Jan; 23(1):24-9. PubMed ID: 15545669
[TBL] [Abstract][Full Text] [Related]
13. Effect of adjuvant systemic treatment on cosmetic outcome and late normal-tissue reactions after breast conservation.
Johansen J; Overgaard J; Overgaard M
Acta Oncol; 2007; 46(4):525-33. PubMed ID: 17497320
[TBL] [Abstract][Full Text] [Related]
14. [Risk of cardiotoxicity of combination treatment radiotherapy and chemotherapy of locally advanced breast carcinoma stage III].
Bustová I
Klin Onkol; 2009; 22(1):17-21. PubMed ID: 19534435
[TBL] [Abstract][Full Text] [Related]
15. [A case report of advanced breast cancer effectively treated by chemo-endocrine therapy with diethylstilbestrol diphosphate and cyclophosphamide].
Hareyama M; Saito A; Oouchi A; Morita K
Gan To Kagaku Ryoho; 1989 Jul; 16(7):2453-6. PubMed ID: 2751322
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy and concomitant irradiation in inflammatory breast cancer.
Tubiana-Mathieu N; Lejeune C; Bonnier P; Genet D; Adjadj DJ; Berda JF; Muracciole X; Delaby F; Clavere P; Benyoub A; Rhein B; Juin B; Piana L
Anticancer Res; 2001; 21(4B):3061-7. PubMed ID: 11712811
[TBL] [Abstract][Full Text] [Related]
17. [Delivery of twins after undergoing adjuvant LHRH analogue and CEF therapy].
Nakagomi H; Hada M; Koshizuka K; Muto S; Takano K
Gan To Kagaku Ryoho; 2003 Apr; 30(4):519-22. PubMed ID: 12722685
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant cyclophosphamide, methotrexate, and fluorouracil in premonopausal patients with node-positive breast cancer: indirect comparison of dose and schedule in DBCG trials 77, 82, and 89.
Ejlertsen B; Mouridsen HT; Jensen MB
Acta Oncol; 2008; 47(4):662-71. PubMed ID: 18465334
[TBL] [Abstract][Full Text] [Related]
19. Thirty-year follow-up of chemo/hormonal therapy in node-positive breast cancer.
Gordon NH; Silverman P; Lasheen W; Meinert J; Siminoff LA
Breast Cancer Res Treat; 2007 May; 102(3):301-12. PubMed ID: 17033926
[TBL] [Abstract][Full Text] [Related]
20. Randomized, controlled trial of cyclophosphamide, methotrexate, and fluorouracil versus cyclophosphamide, doxorubicin, and fluorouracil with and without tamoxifen for high-risk, node-negative breast cancer: treatment results of Intergroup Protocol INT-0102.
Hutchins LF; Green SJ; Ravdin PM; Lew D; Martino S; Abeloff M; Lyss AP; Allred C; Rivkin SE; Osborne CK
J Clin Oncol; 2005 Nov; 23(33):8313-21. PubMed ID: 16293862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
